Even though the FD levels decreased and the FI levels increased in the serum of patients with AMD compared to the control group, our results indicate that the CFH Tyr402His polymorphism does not interfere in the plasma concentrations of the components of the alternative pathway of complement activation. Here, CFH is linked to age-related macular degeneration.